Latest Industry Insights

Certara is developing biosimulation and tech-enabled approaches to help scientists answer key questions at various stages of the development pipeline, serving to inform and accelerate the path to regulatory approval. One such approach, the company’s Vaccine Simulator™, can be leveraged across different therapeutic areas to determine optimal vaccine dosing and dosing regimens for different patient cohorts.

Fitbits, Apple Watches, smartphone apps and other products have become ubiquitous in consumer health tracking. As these technologies quantify and capture users' physiology, they are generating an abundance of data. These data contain a wealth of information that can enable early detection of diseases like diabetes, asthma and heart conditions. But to use this data effectively, a wearable and voiceprint data analysis strategy will be required.

Technology Networks had the pleasure of speaking with Dr. Vladimir Makarov, project manager of the Pistoia Alliance Artificial Intelligence and Machine Learning Centre of Excellence, to learn more about the DataFAIRy project, its aims and importance.

How can R&D leaders turn the huge potential of AI into real-world success? In this article, James Malone, CTO, SciBite (an Elsevier company), looks at five ways to unlock the value of AI.

Technology Networks spoke to James Archetto, vice president at Gaumard Scientific, to learn more about the history of patient simulators, most recent advances and what is on the horizon.

Developing treatments for dementia remains one of the most forbidding challenges facing neurology. Traditionally, paper-based assessments are used by clinicians to diagnose patients. But London-based company Cognetivity says that its AI-based platform could improve diagnostics. We spoke with the company’s co-founder and chief science officer, Dr. Seyed Khaligh-Razavi, to find out more.

Technology Networks recently spoke with Dr. Marvin Ouyang, Cyagen’s executive vice president and chief scientific officer, to learn more about humanized mice and the applications they can benefit. In this interview Dr. Ouyang also explains how humanized mice can be generated and highlights some of Cyagen’s capabilities in this area.

Brain-computer interfaces (BCI) have the potential to revolutionize the lives of people with severe motor and nervous system impairments. But users of current BCI technology must face the hurdle of implanting the device in their brain. We spoke to Professor Florian Solzbacher, co-founder and chairman of Blackrock, to find out more about how neurotechnology companies are overcoming this obstacle.

In this interview, Kevin Wyndham, senior director of research and development at Waters, highlights how a new LC-MS method could be used to support research both during and beyond the COVID-19 pandemic.

Technology Networks spoke with Dr. Bertram Brenig and Illumina to find out more about how studying genetic differences in honey bees will improve breeding programs, and how Illumina will support this research.